Fluoroquinolones in India—Are we prescribing it right: A cost variation study
Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2015, Vol 5, Issue 4
Abstract
Background: Quinolones are the fastest growing antibacterial agents worldwide as they are being used in both the hospitals and community practices to treat infections. Ciprofloxacin and levofloxacin dominate the market mostly, which together charge 65% ($3.3 billion) of global sales. Quinolones such as ciprofloxacin, levofloxacin, and moxifloxacin have been found to possess enormous market capacity and sales volume. Fluoroquinolones in India comprise 30% share of Global Pharmaceuticals Market counterparts. Aims and Objective: To find out the cost of various oral fluoroquinolones available in India either as a single drug or in combination and to evaluate the difference in cost of various brands of same fluoroquinolone by calculating percentage variation in cost in Indian rupees. Material and Methods: Cost of oral fluoroquinolones manufactured by different companies, in the same strength and dosage forms, was obtained from Current Index of Medical Specialties, July–October 2014, and Indian Drug Review, Vol. XXI, Issue No. 4, 2014. The difference in the maximum and minimum price of the same drug manufactured by different pharmaceutical companies and percentage variation in price was calculated. Result: Percentage price variation for various fluoroquinolones was as follows: ofloxacin (200 mg) 869%; sparfloxacin (200 mg) 648%; gemifloxacin (320 mg) 477%; norfloxacin (400 mg) 291%; ciprofloxacin (500 mg) 290%; levofloxacin (250 mg) 264%; lomefloxacin (400 mg) 104%; and moxifloxacin (400 mg) 60%. Among the combination therapy, price variation was norfloxacin + tinidazole (400 + 600 mg) 983%; ofloxacin + cefixime (200 + 200 mg) 232%; levofloxacin + ornidazole (250 + 500 mg) 211%; ofloxacin + ornidazole (200 + 500 mg) 156.60%; and ciprofloxacin + tinidazole (500 + 600 mg) 150%. Conclusion: The average percentage price variation of different brands of same oral fluoroquinolones manufactured in India is very wide. As India is a developing country, clinicians must prescribe fluoroquinolones keeping in mind the cost of therapy.
Authors and Affiliations
Vihang S Chawan, Kalpesh V Gawand, Sagar V Badwane
Clinical profile of chronic daily headache in patient attending tertiary centre
Background: The frequent headache syndrome is among the most challenging disorder that conforms clinician on a routine basis. A major problem with the relatively new form chronic daily headache (CDH) has been its confusi...
Investigation on learning and memory-enhancing activity of Saraca asoca flower (Roxb.) Wilde in experimental mice
Background: Saraca asoca flower (Roxb.) Wilde has been properly used in India for the treatment of uterine tonic and diabetes, and combination of flower and bark was used to treat some neurological disorders in Ayurvedic...
Leptin signaling - Leptin resistance in obesity and its correlation with body mass index
Background: Obesity is a worldwide problem and is a risk factor for multiple health problems. Leptin is an adipokine with a role in energy homeostasis and interruption in its action leads to obesity. Aims and Objectives:...
Knowledge and awareness of disposal of unused and expired medications among medical undergraduates of a tertiary care teaching hospital at B G Nagar: A cross-sectional observational study
Background: Majority of the consumers remain unaware about the disposal of unused or expired medicines. The misuse and improper disposal of medications are a major safety and environmental concern, and therefore the prop...
Gender differences in cardiovascular autonomic milieu and its association with academic performance in young adults
Background: Initiated by biological plausibility and supported by the pilot study, we observed possibility of associations between cardiovascular autonomic milieu and academic performances. As there are established cogni...